Atlas Trials

Extension Study of Patients Successfully Treated by Ziprasidone in Study A1281031

Clinical trial NCT00174447 · COMPLETED

Trial details

NCT number
NCT00174447
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Schizophrenia
Start date
2001-10-01
Primary completion
2008-10-01
Enrollment
43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.